FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126856229> ?p ?o ?g. }

• W3126856229 endingPage "976" @default.
• W3126856229 startingPage "965" @default.
• W3126856229 abstract "Background Preservatives are often necessary components of commercial products. Large-scale North American studies on preservative allergy are limited. Objective To evaluate demographics, positive patch test reactions (PPTRs), clinical relevance, and trends for preservatives tested by the North American Contact Dermatitis Group. Methods We conducted a retrospective cross-sectional analysis of North American Contact Dermatitis Group patch testing results of preservatives from 1994 through 2016. Results A total of 50,799 patients were tested; 11,338 (22.3%) had a PPTR to at least 1 preservative. The most frequent reactions were to methylisothiazolinone 0.2% aqueous (aq) (12.2%), formaldehyde 2% aq (7.8%), formaldehyde 1% aq (7.8%), quaternium-15 2% petrolatum (pet) (7.7%), and methyldibromo glutaronitrile/phenoxyethanol 2% pet (5.1%). Paraben mix 12% pet (1%), iodopropynyl butylcarbamate 0.1% pet (0.4%), benzyl alcohol 1% pet (0.3%), and phenoxyethanol 1% pet (0.2%) had the lowest PPTRs. Linear regression analysis of preservatives tested showed that only methylchloroisothiazolinone/methylisothiazolinone 0.01% aq (parameter estimate, 0.42; 95% CI, 0.17-0.66; P < .005) had a significant increase in PPTRs over time. Limitations Collected variables are dependent on clinical judgment. Results may be prone to referral selection bias. Conclusions This large North American study provides insight on preservative PPTRs and trends from 1994 through 2016. Preservatives are often necessary components of commercial products. Large-scale North American studies on preservative allergy are limited. To evaluate demographics, positive patch test reactions (PPTRs), clinical relevance, and trends for preservatives tested by the North American Contact Dermatitis Group. We conducted a retrospective cross-sectional analysis of North American Contact Dermatitis Group patch testing results of preservatives from 1994 through 2016. A total of 50,799 patients were tested; 11,338 (22.3%) had a PPTR to at least 1 preservative. The most frequent reactions were to methylisothiazolinone 0.2% aqueous (aq) (12.2%), formaldehyde 2% aq (7.8%), formaldehyde 1% aq (7.8%), quaternium-15 2% petrolatum (pet) (7.7%), and methyldibromo glutaronitrile/phenoxyethanol 2% pet (5.1%). Paraben mix 12% pet (1%), iodopropynyl butylcarbamate 0.1% pet (0.4%), benzyl alcohol 1% pet (0.3%), and phenoxyethanol 1% pet (0.2%) had the lowest PPTRs. Linear regression analysis of preservatives tested showed that only methylchloroisothiazolinone/methylisothiazolinone 0.01% aq (parameter estimate, 0.42; 95% CI, 0.17-0.66; P < .005) had a significant increase in PPTRs over time. Collected variables are dependent on clinical judgment. Results may be prone to referral selection bias. This large North American study provides insight on preservative PPTRs and trends from 1994 through 2016." @default.
• W3126856229 created "2021-02-15" @default.
• W3126856229 creator A5001692630 @default.
• W3126856229 creator A5005058453 @default.
• W3126856229 creator A5006454345 @default.
• W3126856229 creator A5011094833 @default.
• W3126856229 creator A5011739266 @default.
• W3126856229 creator A5015520391 @default.
• W3126856229 creator A5019286021 @default.
• W3126856229 creator A5030289968 @default.
• W3126856229 creator A5031933716 @default.
• W3126856229 creator A5035988449 @default.
• W3126856229 creator A5037982488 @default.
• W3126856229 creator A5052928814 @default.
• W3126856229 creator A5058911983 @default.
• W3126856229 creator A5063751569 @default.
• W3126856229 creator A5068691017 @default.
• W3126856229 creator A5070765574 @default.
• W3126856229 creator A5075857386 @default.
• W3126856229 creator A5080239016 @default.
• W3126856229 date "2021-04-01" @default.
• W3126856229 modified "2023-10-10" @default.
• W3126856229 title "Contact dermatitis associated with preservatives: Retrospective analysis of North American Contact Dermatitis Group data, 1994 through 2016" @default.
• W3126856229 cites W1528101120 @default.
• W3126856229 cites W1845345239 @default.
• W3126856229 cites W1966351357 @default.
• W3126856229 cites W1975520445 @default.
• W3126856229 cites W1975837666 @default.
• W3126856229 cites W1991801922 @default.
• W3126856229 cites W2002923275 @default.
• W3126856229 cites W2014200387 @default.
• W3126856229 cites W2020899951 @default.
• W3126856229 cites W2028420675 @default.
• W3126856229 cites W2055414310 @default.
• W3126856229 cites W2058075151 @default.
• W3126856229 cites W2076245669 @default.
• W3126856229 cites W2087648938 @default.
• W3126856229 cites W2107104700 @default.
• W3126856229 cites W2119413730 @default.
• W3126856229 cites W2131253432 @default.
• W3126856229 cites W2131411458 @default.
• W3126856229 cites W2131674113 @default.
• W3126856229 cites W2157360600 @default.
• W3126856229 cites W2206112698 @default.
• W3126856229 cites W2237607878 @default.
• W3126856229 cites W2532220783 @default.
• W3126856229 cites W2558576046 @default.
• W3126856229 cites W2572218770 @default.
• W3126856229 cites W2599259227 @default.
• W3126856229 cites W2605183645 @default.
• W3126856229 cites W2617684929 @default.
• W3126856229 cites W2800800428 @default.
• W3126856229 cites W2803275121 @default.
• W3126856229 cites W2885288423 @default.
• W3126856229 cites W2901446967 @default.
• W3126856229 cites W2901519773 @default.
• W3126856229 cites W2918077839 @default.
• W3126856229 cites W2972455876 @default.
• W3126856229 cites W2995974657 @default.
• W3126856229 cites W4231740210 @default.
• W3126856229 cites W4248364922 @default.
• W3126856229 cites W4251357109 @default.
• W3126856229 cites W4298858641 @default.
• W3126856229 cites W4300646372 @default.
• W3126856229 doi "https://doi.org/10.1016/j.jaad.2020.07.059" @default.
• W3126856229 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8087451" @default.
• W3126856229 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33579596" @default.
• W3126856229 hasPublicationYear "2021" @default.
• W3126856229 type Work @default.
• W3126856229 sameAs 3126856229 @default.
• W3126856229 citedByCount "15" @default.
• W3126856229 countsByYear W31268562292021 @default.
• W3126856229 countsByYear W31268562292022 @default.
• W3126856229 countsByYear W31268562292023 @default.
• W3126856229 crossrefType "journal-article" @default.
• W3126856229 hasAuthorship W3126856229A5001692630 @default.
• W3126856229 hasAuthorship W3126856229A5005058453 @default.
• W3126856229 hasAuthorship W3126856229A5006454345 @default.
• W3126856229 hasAuthorship W3126856229A5011094833 @default.
• W3126856229 hasAuthorship W3126856229A5011739266 @default.
• W3126856229 hasAuthorship W3126856229A5015520391 @default.
• W3126856229 hasAuthorship W3126856229A5019286021 @default.
• W3126856229 hasAuthorship W3126856229A5030289968 @default.
• W3126856229 hasAuthorship W3126856229A5031933716 @default.
• W3126856229 hasAuthorship W3126856229A5035988449 @default.
• W3126856229 hasAuthorship W3126856229A5037982488 @default.
• W3126856229 hasAuthorship W3126856229A5052928814 @default.
• W3126856229 hasAuthorship W3126856229A5058911983 @default.
• W3126856229 hasAuthorship W3126856229A5063751569 @default.
• W3126856229 hasAuthorship W3126856229A5068691017 @default.
• W3126856229 hasAuthorship W3126856229A5070765574 @default.
• W3126856229 hasAuthorship W3126856229A5075857386 @default.
• W3126856229 hasAuthorship W3126856229A5080239016 @default.
• W3126856229 hasBestOaLocation W31268562292 @default.
• W3126856229 hasConcept C140764562 @default.
• W3126856229 hasConcept C144024400 @default.
• W3126856229 hasConcept C149923435 @default.
• W3126856229 hasConcept C16005928 @default.

• next